Clinical Trial Update: Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

View source ↗

Summary

This clinical trial aims to identify genomic predictors of adverse events after cardiac surgery. It is currently recruiting at Brigham and Women's Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Disease
• Heart Failure
• Myocardial Infarction
• Postoperative Cardiac Dysfunction

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery, Genetic Predisposition to Disease | Status: RECRUITING